Treatment Methods and Vaccine Alternatives of COVID-19
Author(s): Sparsh Singhal*, V Wagh and Lokesh
Abstract
COVID-19, which is triggered by the new SARS-CoV-2 virus, is the main reason of mortality in the whole world. This virus outbreak has clearly demonstrated that it is a pandemic.
The global COVID-19 outbreak has galvanized whole scientific community to join forces in the fight against this viral threat. Scientists and huge pharmaceutical companies are working around the clock to discover a cure. This project consists of two parts: first, testing current medications against the COVID-19 onslaughts and second, developing, testing, and manufacturing a harmless and efficacious vaccination as a long-term solution for the pandemic.
At the end of October 2020 COVID-19 had approximately 39000000 cases around the world with almost 1100000 deaths around the globe.
Fever, cough, sore throat, anosmia, difficulty breathing and myalgia are some of the symptoms. There is evidence of immune cells migrating to damaged organs, resulting in overproduction of proinflammatory cytokines that help in the illness process and make the immune system a key component in the COVID-19 infection illness process.
The first clinical trials for Hydroxychloroquine (HCQ), a promising medication, have been halted. The FDA then approved the use of recovered COVID-19 individuals with the same blood group's convalescent serum as a therapeutic option.
Research is going on a number of possible vaccine candidates containing monoclonal antibody as method of eradicating this viral spread.
The motive of this article is to review the recent pharmacological therapies under trial and the various vaccine candidates in development to stop this global pandemic.